Allyson Perry | Authors

Articles

Challenges Abound With Immunotherapy Biomarkers

November 22, 2014

Checkpoint inhibition has demonstrated efficacy for the treatment of melanoma in several clinical trials. However, biomarkers to predict safety and efficacy of immunotherapies in individual melanoma patients are lacking.